In his second full year as CEO at Merck, Robert Davis collected $20.3 million in total pay. (Photo by Kevin Dietsch/Getty Images)
Merck CEO Robert Davis has cracked the $20 million mark in annual pay for the first time, putting him in an exclusive club of biopharma heavy hitters.
Davis, 57, who took over as CEO in 2021 and as chairman the following year, received a 9% bump in pay in 2023 to $20.3 million, according (PDF) to the company’s proxy filing.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,